<html>
<head>
<meta http-equiv="content-type" content="text/html; charset=utf-8">
</head>
<body bgcolor="#FFFFFF" text="#000000">
Team,<br>
<br>
Here is a <b><a
href="https://srsmail-my.sharepoint.com/personal/gfm_securityrs_com/_layouts/15/guestaccess.aspx?guestaccesstoken=2QxXSnxuijrIbiElNuU%2bCJIV0G6FBK5uWbdt0FvvVFg%3d&docid=2_1c5c33062f8ee4dbe9dbf61ba9524ca39">link</a></b>
to a read-only shared copy of the updated Clinical Research (UMA)
use case. It now contains fleshed-out business prerequisites,
sequence diagrams, and some minor corrections.<br>
<br>
Please respond with your suggestions, corrections, etc. But please
do not alter the document itself, as the master Word copy and Visio
graphics are all in my personal cloud storage.<br>
<br>
Note I have not included the final sequence diagram -- review of
disclosures and modification of UMA permissions -- as I'd like to
discuss the proper UMA mechanisms and flow to accomplish the
modifications.<br>
<br>
Also note I have specifically made the AS a singular IRB-selected
element within the use case. All access control policies are
determined by the IRB for ongoing access, with the patient
consenting to them. This also keeps HEART away from ongoing
political, regulatory, and policy matters that are properly out of
scope for our technical work.<br>
<br>
Since I will be at the IHE Connectathon next week, I won't be on our
schedule 1/25 call. Looking forward to discussions on-list and in
February meetings.<br>
<br>
Best,<br>
Glen<br>
<br>
<div class="moz-signature">
<p><b>Glen F. Marshall</b><br>
Consultant<br>
Security Risk Solutions, Inc.<br>
698 Fishermans Bend<br>
Mount Pleasant, SC 29464<br>
Tel: (610) 644-2452<br>
Mobile: (610) 613-3084<br>
<a class="moz-txt-link-abbreviated" href="mailto:gfm@securityrs.com">gfm@securityrs.com</a><br>
<a class="moz-txt-link-abbreviated" href="http://www.SecurityRiskSolutions.com">www.SecurityRiskSolutions.com</a></p>
</div>
</body>
</html>